Tyson Foods stock slips to lowest levels since November 2020 in three-day losing streak

Tyson Foods stock slips to lowest levels since November 2020 in three-day losing streak


A package of Tyson Foods Inc. chicken is arranged for a photograph in Tiskilwa, Illinois.

Daniel Acker | Bloomberg | Getty Images

Tyson Foods hit a 52-week low on Friday in a third-straight down day, a sign that investors are losing confidence in the company amid growing margin pressure and operational issues this year.

The food processor’s stock declined more than 4% this week to trade around $61 per share, its lowest levels since November 2020 and well under its 52-week high of $100.72, notched in February. The stock is down roughly 30% in 2022.

Investment firm Piper Sandler said late Wednesday it was growing “more cautious” on the company as recent months have seen a squeeze on the company’s margins due to the higher costs of cattle-raising and lower retail prices for meat.

Deflating prices of beef and chicken in recent months coupled with rising feeding costs have put broader pressure on the livestock industry.

Staffing shortages and chick-hatching problems have made it difficult for Tyson to keep up with orders, according to a Wall Street Journal report in July. Tyson did not immediately respond to a request for comment.

Piper Sandler projected a three-year average earnings decline of 3.9% from 2023 to 2025. The firm maintains a “hold” rating on the stock with a price target of $68 per share.

Tyson’s tumble extends a downswing for the stock in the second half of the year.

The company posted a strong first quarter with sales rising over 23% to nearly $13 billion, exceeding the company’s own expectations and almost doubling profits.

But Piper Sandler downgraded Tyson shares in May, warning budget-conscious consumers would look for cheaper meat brands as inflation drove up prices.

Though meats, poultry, fish and egg prices were down month over month in November, according to the consumer price index inflation report, the categories are still up nearly 7% over last year.

Barclays and Argus Research also downgraded Tyson this year, citing similar concerns. At least seven major Wall Street firms have “hold” or “sell” ratings on the stock, according to research compiled by FactSet.

— CNBC’s Michael Bloom contributed to this report.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More